Display search results for ** instead (11 products)
20 Jan 2016  |  North America
Transforming Regulations, Reimbursement Models, Healthcare Objectives, and Multiple Stakeholders Usher in Era of Value Based Imaging
External and organic forces are acting in tandem on the medical imaging field: A trickle-down effect from healthcare reform and the Accountable Care Act, together with a transformation operated from within of its business models and value proposition, are combining to push the medical imaging industry decisively into a value-focused environment.\ ...
04 Feb 2016  |  Global
Vital Signs - Spiraling US Drug Costs, Wearable Healthcare Technologies and the Zika Virus, An Analysis
Urgent Remedial Action Required as Nearly 1/4th US Prescription Drug Users Find it Difficult to Afford their Prescriptions
This issue of Vital Signs discusses why the US pays more than other countries for drugs, the inside story on wearable electronics, the spreading Zika virus, and soaring US drug costs.
10 Feb 2016  |  North America
Vital Signs - Technology Developments in Medical Imaging Markets, Radiological Society of North America (RSNA) Meeting 2015
Medical 3D Printing and Medical Imaging Equipment Asset Management Services, Advanced Enterprise Imaging Informatics Seek to Capture Growth Opportunities
\ Frost & Sullivan attended the annual meeting of the Radiological society of North America (RSNA). The four themes we have developed in our coverage of the 2015 edition fall under the topic areas of:\ I- Competitive Landscape and New Business Models, looking at new entrants in the capital imaging equipment arena, the recent developments in techn...
12 Feb 2016  |  Global
Portfolio Expansions Follow Acquisitions by Panasonic Healthcare Holdings Co.,Thermo Fisher Scientific and Abbott Laboratories
This Vital Signs issues discusses Panasonic Healthcare's completed acquisition of Bayer's Diabetes Care Unit, Thermo Fisher Scientific's acquisition of Affymetrix, several moves in the single cell-genomics market by Bio-Rad, Illumina, Qiagen, and 10x Genomics, and Abbott's acquisition of Alere.
19 Feb 2016  |  Global
This edition of Future Tech TechVision Opportunity Engine (TOE) covers optical coherence tomography (OCT), a popular and fast-growing optical medical imaging technology. OCT is a non-ionizing and non-invasive imaging modality, giving it a functional edge over competing technologies. OCT also delivers micron-level resolution, real-time imaging and ...
24 May 2016  |  Global
This Vital Signs issues trends in orphan drugs, genetic research apps, Thermo Fisher Scientific's acquisition of Affymetrix, and the Zika Virus.
03 Jun 2016  |  Global
This edition of the Future Tech TOE highlights key trends and innovations across global hybrid neuroimaging technologies. While providing brief overviews of hybrid neuroimaging innovations, the TOE also covers drivers and challenges, market adoption scenarios, collaborations, and key patents across the global hybrid neuroimaging landscape. Furtherm...
30 Jun 2016  |  Global
This Vital Signs issue discusses Sinocare's acquisition of PTS Diagnostics, biosimilar drug pricing, Americans' usage of prescription pain killers, and Takara Bio's acquistion of Wafergen Bio-systems.
02 Aug 2016  |  Global
This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.
19 Aug 2016  |  Global
This Future Technology TOE depicts new healthcare trends across smart healthcare. The advent of personalized healthcare demands for improved connectivity for telemedicine, remote patient monitoring, electronic health records, and mobile health solutions. Development of applications for the internet of things (IoT) in the healthcare sector is the ke...